REFERENCES
- Pui CH, Campana D, Pei D, . Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741.
- Van Tilburg CM, Sanders EAM, Rovers MM, . Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphoblastic leukemia: a systematic review. Leukemia. 2006;20:1717–1722.
- Hacettepe University Institute of Population Studies, Ministry of Health General Directorate of Mother and Child Health and Family Planning, State Planning Organization and European Union. Ankara, Turkey: Hacettepe University Institute of Population Studies, Turkey Demographic and Health Survey; 2003;11:131–138.
- Unal S, Yetgin S, Cetin M, Gümrük F, . The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse. Pediatr Hematol Oncol. 2004;21:279–289.
- Vauloup-Fellous C, Ursulet-Diser J, Grangeot-Keros L. Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity. Clin Vaccine Immunol. 2007;14:1416–1419.
- Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up. Acta Paediatr. 1995;84:177–182.
- Volc SM, Almeida MT, Abadi MD, . Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia. J Pediatr (Rio J). 2006;82:481–484.
- Kovacs GT, Barany O, Schlick B, . Late immune recovery in children treated for malignant diseases. Pathol Oncol Res. 2008;14:391–397.
- Alanko S, Penicmi T, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer. 1992:69:1481–1486.
- Nilsson A, De Milito A, Engström P, . Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109:e91.
- Brodtman DH, Rosenthal DW, Redner A, . Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr. 2005;146:654–661.
- Zignol M, Peracchi M, Tridello G, . Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101:635–641.
- Tischer A, Gerike E. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine. 2000;18:1382–1392.
- Feldman S, Gigliotti F, Bockhold C, Naegele R. Measles and rubella antibody status in previously vaccinated children with cancer. Med Pediatr Oncol. 1988;16:308–311.
- Yalçın SS, Kanra G, Pehlivan T. Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses. Int J Adolesc Med Health. 2006;18:615–622.
- Patel SR, Ortín M, Cohen BJ, . Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007;44:635–642.
- Ercan TE, Soycan LY, Apak H, . Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27:273–277.
- Feldman S, Andrew M, Norris M, . Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukaemia. Clin Infect Dis. 1998;27:388–390.